+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biologics Safety Testing Market Research Report by Test Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4989657
  • Report
  • April 2022
  • Region: Global
  • 208 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Avance Biosciences Inc.
  • Cytovance Biologics, Inc.
  • Eurofins Scientific Se
  • Lonza Group Ltd.
  • Merck KGaA
  • Sartorius AG
The Global Biologics Safety Testing Market size was estimated at USD 4,309.82 million in 2021, USD 4,868.44 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 13.13% to reach USD 9,039.12 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Biologics Safety Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Test Type, the market was studied across Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication and Characterization Tests, Endotoxin Tests, Residual Host Contaminant Detection Tests, and Sterility Tests.
  • Based on Application, the market was studied across Blood and Blood-Related Products Testing, Cellular and Gene Therapy, Stem Cell Research, Tissue and Tissue-Related Products Testing, and Vaccine & Therapeutics Development.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biologics Safety Testing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Safety Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Safety Testing Market, including Avance Biosciences Inc., Charles River Laboratories International, Inc., Cytovance Biologics, Inc., Eurofins Scientific Se, Lonza Group Ltd., Merck KGaA, Pace Analytical Services Inc., Sartorius AG, Source Bioscience, Thermo Fisher Scientific Inc., Toxikon Corporation, and Wuxi Apptec.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Biologics Safety Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Safety Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Safety Testing Market?
4. What is the competitive strategic window for opportunities in the Global Biologics Safety Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Biologics Safety Testing Market?
6. What is the market share of the leading vendors in the Global Biologics Safety Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Biologics Safety Testing Market?
Frequently Asked Questions about the Global Biologics Safety Testing Market

What is the estimated value of the Global Biologics Safety Testing Market?

The Global Biologics Safety Testing Market was estimated to be valued at $4309.8 Million in 2021.

What is the growth rate of the Global Biologics Safety Testing Market?

The growth rate of the Global Biologics Safety Testing Market is 13.1%, with an estimated value of $9039.1 Million by 2027.

What is the forecasted size of the Global Biologics Safety Testing Market?

The Global Biologics Safety Testing Market is estimated to be worth $9039.1 Million by 2027.

Who are the key companies in the Global Biologics Safety Testing Market?

Key companies in the Global Biologics Safety Testing Market include Avance Biosciences Inc., Charles River Laboratories International, Inc., Cytovance Biologics, Inc., Eurofins Scientific Se, Lonza Group Ltd., Merck KGaA, Pace Analytical Services Inc., Sartorius AG and Thermo Fisher Scientific Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Avance Biosciences Inc.
  • Cytovance Biologics, Inc.
  • Eurofins Scientific Se
  • Lonza Group Ltd.
  • Merck KGaA
  • Sartorius AG

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in the number of drug launches due to high disease burden
5.1.1.2. Rising number of government initiatives
5.1.1.3. Growing size of the biotechnology industry
5.1.2. Restraints
5.1.2.1. Lack of skilled professionals
5.1.3. Opportunities
5.1.3.1. Rising pharmaceutical industries and increasing innovation in the pharmaceutical sector
5.1.3.2. Increasing research and development investment in life sciences and clinical research
5.1.4. Challenges
5.1.4.1. High-cost requirement for development of drugs
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Biologics Safety Testing Market, by Test Type
6.1. Introduction
6.2. Adventitious Agent Detection Tests
6.3. Bioburden Tests
6.4. Cell Line Authentication and Characterization Tests
6.5. Endotoxin Tests
6.6. Residual Host Contaminant Detection Tests
6.7. Sterility Tests
7. Biologics Safety Testing Market, by Application
7.1. Introduction
7.2. Blood and Blood-Related Products Testing
7.3. Cellular and Gene Therapy
7.4. Stem Cell Research
7.5. Tissue and Tissue-Related Products Testing
7.6. Vaccine & Therapeutics Development
8. Americas Biologics Safety Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Biologics Safety Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Biologics Safety Testing Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Avance Biosciences Inc.
12.2. Charles River Laboratories International, Inc.
12.3. Cytovance Biologics, Inc.
12.4. Eurofins Scientific Se
12.5. Lonza Group Ltd.
12.6. Merck KGaA
12.7. Pace Analytical Services Inc.
12.8. Sartorius AG
12.9. Source Bioscience
12.10. Thermo Fisher Scientific Inc.
12.11. Toxikon Corporation
12.12. Wuxi Apptec
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL BIOLOGICS SAFETY TESTING MARKET: DYNAMICS
FIGURE 2. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2027
FIGURE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 18. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2027
FIGURE 20. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. GLOBAL BIOLOGICS SAFETY TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 61. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 62. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL BIOLOGICS SAFETY TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 25. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 30. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 32. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 43. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY STATE, 2019-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 51. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 53. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 56. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 58. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SCORES
TABLE 91. GLOBAL BIOLOGICS SAFETY TESTING MARKET: BUSINESS STRATEGY
TABLE 92. GLOBAL BIOLOGICS SAFETY TESTING MARKET: PRODUCT SATISFACTION
TABLE 93. GLOBAL BIOLOGICS SAFETY TESTING MARKET: RANKING
TABLE 94. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 95. GLOBAL BIOLOGICS SAFETY TESTING MARKET: MERGER & ACQUISITION
TABLE 96. GLOBAL BIOLOGICS SAFETY TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 97. GLOBAL BIOLOGICS SAFETY TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 98. GLOBAL BIOLOGICS SAFETY TESTING MARKET: INVESTMENT & FUNDING
TABLE 99. GLOBAL BIOLOGICS SAFETY TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 100. GLOBAL BIOLOGICS SAFETY TESTING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Avance Biosciences Inc.
  • Charles River Laboratories International, Inc.
  • Cytovance Biologics, Inc.
  • Eurofins Scientific Se
  • Lonza Group Ltd.
  • Merck KGaA
  • Pace Analytical Services Inc.
  • Sartorius AG
  • Source Bioscience
  • Thermo Fisher Scientific Inc.
  • Toxikon Corporation
  • Wuxi Apptec
Note: Product cover images may vary from those shown

Loading
LOADING...